Semaglutide.
The GLP-1 everyone's talking about.
A compounded GLP-1 receptor agonist prescribed by licensed clinicians and prepared by US pharmacies. Designed to support appetite regulation and weight management goals.
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist — a compound that mimics a hormone your body already produces after eating. It works with your body's existing appetite regulation pathways to support feelings of fullness and reduce food noise, that constant background hum of thinking about your next meal.
It belongs to the same class of compounds as the well-known branded weight management medications. PepScribe's semaglutide is compounded by licensed US 503A/503B pharmacies under a prescription from your assigned clinician.
This isn't a crash diet or a hack. It's a tool that works alongside the biology you already have — supporting your body while you build the habits that stick.
Is semaglutide right for you?
Semaglutide may be a good fit if several of these resonate with where you are right now.
Your PepScribe clinician makes the final call on eligibility based on your health history and goals. The assessment is free and takes about 3 minutes.
How semaglutide works
GLP-1 pathway activation
Semaglutide binds to GLP-1 receptors in the brain, supporting the signaling pathways that regulate appetite and satiety. This may help reduce overall caloric intake by working with your body's natural hunger signals.
Once-weekly injection
Subcutaneous injection, once per week. Your clinician will start you at a lower dose and titrate up based on your response and tolerability. Most people self-administer at home with a small insulin-style needle.
What to expect early on
Many patients notice reduced appetite within the first few weeks. Some GI side effects (nausea, mostly) are common during dose titration and typically improve as your body adjusts. Your clinician monitors your progress throughout.
What to expect
Everyone responds differently. Here's a general timeline based on what patients commonly report.
Appetite shifts
Many patients report a noticeable drop in food noise within the first 2–3 weeks. Portions naturally get smaller. Cravings — especially for high-calorie comfort foods — tend to quiet down. Mild nausea during dose titration is common and typically fades.
New relationship with food
Side effects generally improve. Eating patterns start to feel different — not restrictive, just quieter. Many patients report they can eat a normal meal and actually feel satisfied. Progress toward weight management goals typically becomes visible during this window.
Habits take over
At maintenance dose, the medication supports the dietary and lifestyle patterns you've been building. Many patients describe this phase as feeling like their appetite is simply “normal” again. Your clinician adjusts the plan as your goals evolve.
Individual results may vary. Timelines are based on commonly reported patient experiences and are not guaranteed outcomes.
Side effects — the honest version
No medication is free of side effects. Here's what the data and patient experience actually look like.
Common (may affect many patients)
- •Nausea — most common, especially during dose increases. Usually transient.
- •Constipation or diarrhea
- •Headache
- •Fatigue
- •Injection site reactions
Less common but worth knowing
- •Pancreatitis (rare — seek immediate medical attention for severe abdominal pain)
- •Gallbladder issues
Talk to your clinician if you experience persistent or worsening side effects. Your PepScribe clinician is available to adjust your dosing or address concerns throughout your treatment.
Join the waitlist for early access pricing
We're finalizing semaglutide pricing. Join the waitlist to lock in early access rates before we go live.
No spam. No commitment. Just early access when we launch.
Deep dives on Semaglutide
Research-backed articles covering specific topics in depth.
See if semaglutide is right for you.
A quick assessment to see if semaglutide is right for you. No commitments. No pressure. Takes about 3 minutes.
Start your semaglutide assessmentCompounded medications are prepared by licensed pharmacies and are not FDA-approved. All prescriptions require approval by a licensed healthcare provider. Individual results may vary.